Cresco Labs Inc. (CRLBF) Reports Q3 Loss, Misses Revenue Estimates
Portfolio Pulse from
Cresco Labs Inc. (CRLBF) reported a Q3 loss of $0.02 per share, missing the Zacks Consensus Estimate of a $0.01 loss. This is an improvement from the $0.04 loss per share a year ago.
November 09, 2024 | 1:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cresco Labs Inc. reported a Q3 loss of $0.02 per share, missing the expected loss of $0.01. Despite missing estimates, the loss is smaller than last year's $0.04 per share.
The reported loss of $0.02 per share is worse than the expected $0.01 loss, which is likely to negatively impact the stock price in the short term. However, the improvement from last year's $0.04 loss may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100